Translational Behavioral Medicine, published by Oxford University Press, is a premier academic journal dedicated to advancing the field of behavioral medicine through high-quality research and innovative methodologies. With an ISSN of 1869-6716 and an impressive E-ISSN of 1613-9860, the journal serves as a vital platform for disseminating findings that bridge the gap between laboratory research and clinical practice. Ranking in the prestigious Q1 category for both Applied Psychology and Behavioral Neuroscience, it holds a prominent position within the academic community, as reflected by its Scopus rankings—17th out of 88 in Behavioral Neuroscience and 57th out of 249 in Applied Psychology. Although currently non-Open Access, the journal provides a wealth of knowledge for researchers, professionals, and students interested in the interplay of behavioral science and health. With converged years from 2011 to 2024, Translational Behavioral Medicine continues to be an essential resource for those committed to enhancing our understanding of how behavioral factors contribute to health and illness.

Tobacco Use Insights is a leading open-access journal dedicated to advancing the understanding of tobacco use and its implications for public health. Published by SAGE Publications Ltd, this journal provides a platform for innovative research, critical reviews, and practice-oriented articles that span the diverse dimensions of tobacco consumption, cessation, policy impacts, and prevention strategies. With a commitment to facilitating knowledge dissemination since its inception in 2009, Tobacco Use Insights serves an international audience of researchers, health professionals, and students who are engaged in the ongoing fight against tobacco-related health issues. The journal is indexed and accessible across multiple databases, reinforcing its influence within the field and ensuring wide visibility for its contributors. The journal's insightful contributions play an essential role in shaping effective tobacco control policies and fostering healthier communities globally.

Journal of Inflammation-London, published by BMC, is a premier open access journal dedicated to advancing the understanding of inflammation, a critical process underlying numerous diseases including autoimmune disorders, cancer, and cardiovascular conditions. With its inception in 2004, the journal has consistently delivered high-quality research that bridges basic science and clinical applications, maintaining a significant place in the academic community. It holds impressive rankings within the Q2 category for both Cell Biology and Clinical Biochemistry, reflecting its impactful contributions to these fields, where it ranks in the 73rd and 64th percentiles respectively. The journal is committed to open access principles, ensuring that all published articles are freely available to researchers, practitioners, and the global community, thereby fostering collaboration and innovation. Located in the United Kingdom, the journal continues to attract submissions from prominent researchers and institutions worldwide, solidifying its status as an essential resource for the latest developments in inflammation research.

Welcome to Epidemiology and Health, a premier open-access journal dedicated to advancing knowledge in the fields of epidemiology and public health. Published by the Korean Society of Epidemiology since 1979, this journal serves as a vital platform for researchers, professionals, and students alike, promoting innovative research and robust discussion surrounding public health issues. Based in South Korea, it boasts a commendable Q2 ranking in the categories of Epidemiology, Public Health, and Environmental and Occupational Health, reflecting its significant contribution to the scientific community. With its current impact factor ranking it favorably among peers—#124 out of 665 in Public Health and #40 out of 148 in Epidemiology—Epidemiology and Health continues to uphold its mission of disseminating high-quality, peer-reviewed research. The journal's commitment to open access ensures that vital epidemiological insights reach a broad audience, supporting the collective goal of improving global health outcomes. Engage with pioneering studies and emerging trends within these critical fields, as we work towards a healthier future.

International Journal of Injury Control and Safety Promotion, published by Taylor & Francis Ltd, is a pivotal academic platform dedicated to advancing the field of public health and safety research. With an ISSN of 1745-7300 and an E-ISSN of 1745-7319, this journal is based in the United Kingdom and encompasses a wide range of topics related to injury prevention, safety promotion, and environmental health. Established in 2005, it stands out with a commendable Q2 ranking in both the Public Health and Safety Research categories for the year 2023, reflecting its significant influence in these domains. The Scopus rankings also highlight its stature, placing it in the 75th and 66th percentiles within its respective fields. Although the journal does not offer open access, its comprehensive reviews, original research articles, and critical commentaries provide essential insights for researchers, professionals, and students dedicated to improving health outcomes and promoting safety. By fostering interdisciplinary collaboration and disseminating innovative findings, the International Journal of Injury Control and Safety Promotion plays a crucial role in shaping the future of public health strategies and interventions.

NICOTINE & TOBACCO RESEARCH, published by Oxford University Press, is a leading journal dedicated to advancing the understanding of nicotine and tobacco-related issues through rigorous research and analysis. Established in 1999, this esteemed journal has become a critical resource for scholars and practitioners in the fields of public health, environmental, and occupational health, maintaining a prestigious Q1 classification in its category as of 2023. With an impressive ranking of 67 out of 665 in the Scopus database, placing it in the 90th percentile, it is recognized for its high-quality contributions that resonate with current global health challenges. Although open access options are not available, the journal’s articles are accessible to a broad audience, ensuring that cutting-edge research reaches those who need it most. As it looks toward 2024 and beyond, NICOTINE & TOBACCO RESEARCH remains committed to promoting innovative research that informs policies and practices aimed at reducing tobacco use and its associated harms, thus playing a pivotal role in enhancing public health worldwide.

Clinical Epidemiology and Global Health, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a leading open-access journal dedicated to the dissemination of research in the crucial fields of epidemiology and global health. With an ISSN of 2452-0918 and an E-ISSN of 2213-3984, this journal has been a platform for innovative studies since its inception in 2013, converging into a comprehensive resource through 2024. Operating from the Netherlands and ensuring accessibility from anywhere in the world since its transition to an open-access model in 2021, it fosters the global exchange of knowledge. The journal's impact is reflected in its current quartile rankings, including Q2 in Public Health, Environmental and Occupational Health and Q3 in Epidemiology, Infectious Diseases, and Microbiology. With a growing reputation bolstered by SCOPUS rankings that place it in the top percentiles, Clinical Epidemiology and Global Health stands as an essential resource for researchers, professionals, and students dedicated to advancing public health and epidemiological research.

Allergy Asthma & Respiratory Disease is a pioneering journal dedicated to advancing research and clinical practice in the fields of allergy, asthma, and related respiratory diseases. Published by the esteemed Korean Academy of Asthma Allergy & Clinical Immunology, this journal aims to disseminate high-quality, peer-reviewed articles that contribute to the understanding, diagnosis, and treatment of these prevalent health issues. Although it operates under a subscription model, it maintains a robust reputation for being a pivotal resource in respiratory health, attracting authors and researchers worldwide. The journal emphasizes interdisciplinary approaches and encourages submissions that span from molecular biology to public health perspectives, making it a vital platform for professionals, researchers, and students eager to deepen their knowledge in respiratory medicine. With a commitment to fostering academic discourse in South Korea and beyond, Allergy Asthma & Respiratory Disease is positioned as a significant contributor to the global conversation on respiratory health.

DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, published by WILEY, is a leading peer-reviewed journal dedicated to advancing the understanding of alcohol use and its clinical implications. With an impressive impact factor and categorized in the top quartile (Q1) in Medicine (miscellaneous), Psychiatry and Mental Health, and Toxicology, this journal serves a crucial role in disseminating high-quality research that informs clinical practice and health policy. The journal’s scope encompasses a wide range of topics related to alcohol use, including its effects on mental health, addiction, and public health, providing a vital platform for professionals, researchers, and students committed to enhancing knowledge in the field. The journal operates in the United States and is known for its rigorous editorial standards, ensuring that published articles contribute valuable insights to ongoing discussions in medicine and behavioral health. As of 2023-2024, the journal continues to thrive in a competitive academic landscape, aiming to foster collaboration and innovation in alcohol-related research.